Post-Ablation Pericarditis Reduction Study (PAPERS)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 248 participants.
Also called NCT06731595
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 248 participants
- Registry
-
NCT06731595
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT06731595. Randomized; no masking; primary purpose prevention. Start 2021-05-20 (actual); primary completion 2022-01-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Post-Ablation Pericarditis Reduction Study (PAPERS)
- Acronym
- PAPERS
- Condition
- Atrial Fibrillation
- Condition
- Catheter Ablation
- Condition
- Pericarditis
- Intervention (Drug)
- Colchicine
- Lead sponsor
- St. Vincent Cardiovascular Research Institute
- Collaborator
- Asenson Sacred Heart - Pensacoloa, FL
Record details
- Record id
cardio:ct-nct06731595- Content hash
61f0441645506007d6eb9fa0afa5fb5f479474dcade8450181847040c4c2f1c2